Related Experiment Videos
Principles of antibiotic therapy
1Department of Surgery, University of Cincinnati College of Medicine, Ohio.
The Surgical Clinics of North America
|June 1, 1994
Summary
New antibiotics and combination therapies combat Gram-negative surgical infections. Beta-lactamase inhibitors and optimized aminoglycoside dosing are key strategies against resistant bacteria.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Beta-lactamase enzymes are increasingly important in Gram-negative bacterial resistance to antibiotics.
- This has reduced the effectiveness of established antibiotic treatments for surgical infections.
Purpose of the Study:
- To review the mechanisms of beta-lactamases.
- To describe new antibiotic agents and their efficacy against resistant Gram-negative organisms.
- To discuss the role of combination therapy and optimized dosing in treating severe Gram-negative infections.
Main Methods:
- Literature review of recent developments in antibiotic treatment for surgical infections.
- Analysis of beta-lactamase mechanisms and activity of new antimicrobial agents.
- Evaluation of combination therapy and aminoglycoside dosing strategies.
Main Results:
- New cephalosporins, carbapenems, quinolones, and beta-lactamase inhibitors have been developed.
- These agents show activity against Gram-negative organisms resistant to older drugs.
- Combination therapy and optimized aminoglycoside dosing are effective strategies.
Conclusions:
- New antibiotic agents and strategies are crucial for managing Gram-negative bacterial resistance.
- Understanding beta-lactamase mechanisms guides the development of effective treatments.
- Optimized therapeutic regimens improve outcomes for severe Gram-negative infections.